A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...

Kazia Therapeutics (KZIA) announced a research grant awarded from The Michael J. Fox Foundation for Parkinson’s Research, MJFF, to fund ...

Duke is on a mission to do all of this — and more.

A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling process and create ...

Genome-wide association studies (GWASs) have linked genetic variants to neuropsychiatric disorders, but their regulatory roles in non-coding regions remain largely unclear. Using the LUHMES neuronal ...

A new study links mitochondrial dysfunction to Crohn’s disease, shifting how scientists approach treatment and opening doors ...

Read these five stories to catch up on what you may have missed this week!

STOCKHOLM, SWEDEN / ACCESS Newswire / February 17, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for ...